Glutathione Depletion and Concomitant Elevation of Susceptibility in Patients with Parkinson's Disease: State-of-the-Art MR Spectroscopy and Neuropsychological Study.
Level 4 - case-series / case-control
Case-control study comparing imaging biomarkers between clinical cases and healthy controls
PubMed 38050970 · doi:10.1021/acschemneuro.3c00717
What was done
Investigators evaluated oxidative stress and iron accumulation in 38 patients with Parkinson's disease (PD) and 30 age-matched healthy controls (HC). Participants underwent magnetic resonance spectroscopy to measure glutathione (GSH) in the substantia nigra (SN) and left hippocampus (LH), and γ-aminobutyric acid (GABA) in the SN. Quantitative susceptibility mapping (QSM) was acquired from both regions. Participants also completed motor and neuropsychological cognitive assessments.
What was found
Glutathione levels were significantly reduced and susceptibility was significantly increased in the SN of PD patients compared to HC. In the LH, GSH was significantly depleted, but susceptibility showed no alteration. GABA depletion in the SN was not statistically significant. PD patients exhibited significant cognitive impairment, and GSH depletion was negatively correlated with motor function performance. Combining SN GSH, GABA, and susceptibility in a multivariate ROC analysis yielded a diagnostic accuracy of 86.1%, compared to individual accuracies of 65.8% for GSH, 69.6% for susceptibility, and 57.5% for GABA. Absolute concentrations and exact p-values were not provided in the abstract.
Why it matters
This study provides in vivo evidence that linking substantia nigra antioxidant depletion with iron enhancement significantly improves diagnostic accuracy for Parkinson's disease compared to evaluating single imaging biomarkers.
Limits
The study is limited by a modest sample size of 68 total participants and a cross-sectional case-control design that cannot evaluate disease progression. The hippocampus was only assessed unilaterally on the left, and exact biomarker values, confidence intervals, and patient medication statuses were not reported in the abstract.
Cited by
- supports Parkinson's disease is characterized by a deficiency of the antioxidant glutathione in specific regions of the brain.